Nifurtimox

Nifurtimox

SCHEMBL28086189

CC1CS(=O)(=O)CCN1N=Cc1ccc([N+](=O)[O-])o1.O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.60
ALDH1A1 P00352 6/20 0.60
CYP2D6 P10635 2/20 0.55
CYP3A4 P08684 1/20 0.55
OPRK1 P41145 1/20 0.55
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
THRB P10828 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPT P10636 5/20 0.37
POLB P06746 2/20 0.37
KDM4E B2RXH2 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
MITF O75030 2/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nifurtimox SCHEMBL1650162 0.78 LMNA (1.00) LMNAALDH1A1CYP2D6CYP3A4CYP2C19
Nifurtimox SCHEMBL60839 0.78 LMNA (1.00) LMNAALDH1A1CYP2D6CYP3A4CYP2C19
Nifurtimox SCHEMBL9910611 0.78 LMNA (1.00) LMNAALDH1A1CYP2D6CYP3A4CYP2C19
Nifurtimox SCHEMBL60840 0.78 LMNA (1.00) LMNAALDH1A1CYP2D6CYP3A4CYP2C19
Nifurtimox SCHEMBL2326415 0.77 LMNA (0.83) LMNAALDH1A1CYP2D6CYP3A4MAPT
Benznidazole SCHEMBL45081 0.74 CYP3A4 (1.00) LMNAALDH1A1CYP2D6CYP3A4OPRK1
Nifurtimox SCHEMBL4727154 0.73 LMNA (0.85) LMNAALDH1A1CYP2D6CYP3A4THRB
Nifurtimox SCHEMBL2326559 0.71 LMNA (0.70) LMNAALDH1A1CYP2D6CYP3A4MAPT
SCHEMBL23003602 0.70 LMNA (0.78) LMNAALDH1A1CYP2D6CYP3A4MAPT
SCHEMBL23003603 0.70 LMNA (0.78) LMNAALDH1A1CYP2D6CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed